» Articles » PMID: 23593005

The JAK-STAT Transcriptional Regulator, STAT-5, Activates the ATM DNA Damage Pathway to Induce HPV 31 Genome Amplification Upon Epithelial Differentiation

Overview
Journal PLoS Pathog
Specialty Microbiology
Date 2013 Apr 18
PMID 23593005
Citations 66
Authors
Affiliations
Soon will be listed here.
Abstract

High-risk human papillomavirus (HPV) must evade innate immune surveillance to establish persistent infections and to amplify viral genomes upon differentiation. Members of the JAK-STAT family are important regulators of the innate immune response and HPV proteins downregulate expression of STAT-1 to allow for stable maintenance of viral episomes. STAT-5 is another member of this pathway that modulates the inflammatory response and plays an important role in controlling cell cycle progression in response to cytokines and growth factors. Our studies show that HPV E7 activates STAT-5 phosphorylation without altering total protein levels. Inhibition of STAT-5 phosphorylation by the drug pimozide abolishes viral genome amplification and late gene expression in differentiating keratinocytes. In contrast, treatment of undifferentiated cells that stably maintain episomes has no effect on viral replication. Knockdown studies show that the STAT-5β isoform is mainly responsible for this activity and that this is mediated through the ATM DNA damage response. A downstream target of STAT-5, the peroxisome proliferator-activated receptor γ (PPARγ) contributes to the effects on members of the ATM pathway. Overall, these findings identify an important new regulatory mechanism by which the innate immune regulator, STAT-5, promotes HPV viral replication through activation of the ATM DNA damage response.

Citing Articles

STAT5 Is Necessary for the Metabolic Switch Induced by IL-2 in Cervical Cancer Cell Line SiHa.

Valle-Mendiola A, Rocha-Zavaleta L, Maldonado-Lagunas V, Morelos-Laguna D, Gutierrez-Hoya A, Weiss-Steider B Int J Mol Sci. 2024; 25(13).

PMID: 38999946 PMC: 11241652. DOI: 10.3390/ijms25136835.


Interferon-γ-induced GBP1 is an inhibitor of human papillomavirus 18.

Xu M, Lin M, Li Z BMC Womens Health. 2024; 24(1):240.

PMID: 38622605 PMC: 11017553. DOI: 10.1186/s12905-024-03057-4.


Comparative Analysis of Alpha and Beta HPV E6 Oncoproteins: Insights into Functional Distinctions and Divergent Mechanisms of Pathogenesis.

Skelin J, Tomaic V Viruses. 2023; 15(11).

PMID: 38005929 PMC: 10674601. DOI: 10.3390/v15112253.


JAK/STAT Signaling and Cervical Cancer: From the Cell Surface to the Nucleus.

Valle-Mendiola A, Gutierrez-Hoya A, Soto-Cruz I Genes (Basel). 2023; 14(6).

PMID: 37372319 PMC: 10298571. DOI: 10.3390/genes14061141.


For Better or Worse: Modulation of the Host DNA Damage Response by Human Papillomavirus.

Studstill C, Moody C Annu Rev Virol. 2023; 10(1):325-345.

PMID: 37040798 PMC: 10956471. DOI: 10.1146/annurev-virology-111821-103452.


References
1.
Fradet-Turcotte A, Bergeron-Labrecque F, Moody C, Lehoux M, Laimins L, Archambault J . Nuclear accumulation of the papillomavirus E1 helicase blocks S-phase progression and triggers an ATM-dependent DNA damage response. J Virol. 2011; 85(17):8996-9012. PMC: 3165840. DOI: 10.1128/JVI.00542-11. View

2.
Juffroy O, Bugault F, Lambotte O, Landires I, Viard J, Niel L . Dual mechanism of impairment of interleukin-7 (IL-7) responses in human immunodeficiency virus infection: decreased IL-7 binding and abnormal activation of the JAK/STAT5 pathway. J Virol. 2009; 84(1):96-108. PMC: 2798395. DOI: 10.1128/JVI.01475-09. View

3.
Mighty K, Laimins L . p63 is necessary for the activation of human papillomavirus late viral functions upon epithelial differentiation. J Virol. 2011; 85(17):8863-9. PMC: 3165790. DOI: 10.1128/JVI.00750-11. View

4.
Lee J, Paull T . Direct activation of the ATM protein kinase by the Mre11/Rad50/Nbs1 complex. Science. 2004; 304(5667):93-6. DOI: 10.1126/science.1091496. View

5.
Munger K, Werness B, Dyson N, Phelps W, Harlow E, Howley P . Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J. 1989; 8(13):4099-105. PMC: 401588. DOI: 10.1002/j.1460-2075.1989.tb08594.x. View